Overview

Open Clinical Study, Comparing Non-inferiority of Chronic Plaque Psoriasis

Status:
Suspended
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is: To evaluate the efficacy of the drugs under study for treating chronic plaque psoriasis. - Population: 50 patients will be selected from both sexes, healthy, between 18 and 65 years with a clinical diagnosis of chronic plaque psoriasis with PASI <20%, according to the criteria of inclusion and exclusion.
Details
Lead Sponsor:
Glenmark FarmacĂȘutica Ltda
Treatments:
Calcipotriene
Nicotinic Acids
Tazarotene